Blueprint Medicines Corp【BPMC】
| Dec 31,
2015 | Dec 31,
2016 | Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 | Dec 31,
2024 |
|---|
| Product | - | - | - | - | - | 22 | 58 | 111 | 204 | 479 |
|---|
| Collaboration, License and Other | - | - | - | - | - | - | - | - | 45 | 30 |
|---|
| License | - | - | - | - | - | - | - | 28 | - | - |
|---|
| Revenue | - | - | - | 45 | 67 | 794 | 180 | 204 | 249 | 509 |
|---|
| Cost of sales | - | - | - | - | - | 0 | 18 | 18 | 9 | 20 |
|---|
| Research and development | 49 | 81 | 145 | 244 | 331 | 327 | 601 | 477 | 428 | 341 |
|---|
| Selling, general and administrative | - | - | - | - | - | 158 | 195 | 237 | 295 | 359 |
|---|
| Collaboration loss sharing | - | - | - | - | - | - | 8 | 9 | 4 | - |
|---|
| Total cost and operating expenses | - | - | - | - | - | 485 | 822 | 742 | 736 | 721 |
|---|
| Interest expense, net | - | - | - | - | - | - | - | - | - | -28 |
|---|
| Other income (expense), net | -0 | 1 | 3 | 10 | -0 | -0 | -1 | 2 | -1 | 1 |
|---|
| Debt extinguishment gain | - | - | - | - | - | - | - | - | - | 174 |
|---|
| Total other income (expense) | -1 | 0 | 3 | 10 | 14 | 6 | 1 | -15 | -20 | 146 |
|---|
| Loss before income taxes | - | - | - | - | - | 315 | -641 | -552 | -506 | -66 |
|---|
| Income tax expense | - | - | - | - | - | 1 | 3 | 5 | 1 | 1 |
|---|
| Net loss | -53 | -72 | -148 | -237 | -348 | 314 | -644 | -558 | -507 | -67 |
|---|
| Unrealized gain (loss) on pension benefit obligations | - | - | - | - | -3 | -3 | 4 | 1 | -3 | -1 |
|---|
| Unrealized gain (loss) on available-for-sale investments | - | -0 | -0 | 0 | 1 | 0 | -4 | -7 | 10 | 1 |
|---|
| Currency translation adjustments | - | - | - | -0 | -0 | -0 | 0 | 0 | -0 | 0 |
|---|
| Comprehensive loss | - | -73 | -148 | -237 | -350 | 311 | -643 | -564 | -500 | -67 |
|---|
| Earnings Per Share, Basic | - | - | - | - | - | 5.76 | -11.01 | -9.35 | -8.37 | -1.07 |
|---|
| Earnings Per Share, Diluted | - | - | - | - | - | 5.59 | -11.01 | -9.35 | -8.37 | -1.07 |
|---|